Bradley Monk named medical director of late-phase clinical research at Florida Cancer Specialists

Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began

One year after the Centers for Medicare & Medicaid Services made the decision to pay for patient navigation services, data from early adopters show that navigation services are leading to better outcomes, significant cost savings for healthcare systems, and mitigation of health inequities.

Phase III trial of subcutaneous pembrolizumab with berahyaluronidase alfa meets primary endpoints

Merck announced positive topline results from the pivotal phase III MK-3475A-D77 trial.

November 22, 2024

Vol.50 No.44

Clinical Roundup

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

Researchers at City of Hope found that taking white button mushroom pills reduces a class of immune cells called myeloid-derived suppressor cells, which has been linked to cancer development and spread.

November 22, 2024

Vol.50 No.44

Clinical Roundup

Nivolumab + epigenetic drug induce immune response in some resistant pancreatic cancers

In a phase II clinical trial, a research team led by Nilofer Azad, professor of oncology and co-leader of the Kimmel Cancer Center’s Cancer Genetics and Epigenetics Program, and Marina Baretti, the Jiasheng Chair in Hepato-Biliary Cancer at the Kimmel Cancer Center, tested the safety and efficacy of the combination of two drugs: an immunotherapy, nivolumab, and an epigenetic drug, entinostat—a histone deacetylase inhibitor.

November 22, 2024

Vol.50 No.44

Clinical Roundup

Model created by Cedars-Sinai investigators could speed patient selection for clinical trials

A group of investigators led by Cedars-Sinai have developed and successfully tested a new artificial intelligence method to make launching cancer clinical trials easier and faster. The method uses patients’ pathology reports to automate the classification of patients by the severity of their cancers, potentially shortening the process of selecting candidates for clinical trials.

November 22, 2024

Vol.50 No.44

Drugs & Targets

Immunai to collaborate with Teva to enhance clinical decision making in immuno-oncology clinical trials

Immunai Inc. announced a multi-year collaboration with Teva Pharmaceuticals, an affiliate of Teva Pharmaceutical Industries Ltd. Under the agreement, Immunai will collaborate with Teva in immunology and Immuno-oncology programs.

November 22, 2024

Vol.50 No.44

Bradley Monk named medical director of late-phase clinical research at Florida Cancer Specialists

YOU MAY BE INTERESTED IN

Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began

Phase III trial of subcutaneous pembrolizumab with berahyaluronidase alfa meets primary endpoints

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

Nivolumab + epigenetic drug induce immune response in some resistant pancreatic cancers

Model created by Cedars-Sinai investigators could speed patient selection for clinical trials

Immunai to collaborate with Teva to enhance clinical decision making in immuno-oncology clinical trials

Renew today!

Subscriber content

Never miss an issue!

Login

Bradley Monk named medical director of late-phase clinical research at Florida Cancer Specialists

YOU MAY BE INTERESTED IN

Patient navigation benefits health systems, improves careInitial data presented at the White House come a year after CMS payment began

Phase III trial of subcutaneous pembrolizumab with berahyaluronidase alfa meets primary endpoints

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

Nivolumab + epigenetic drug induce immune response in some resistant pancreatic cancers

Model created by Cedars-Sinai investigators could speed patient selection for clinical trials

Immunai to collaborate with Teva to enhance clinical decision making in immuno-oncology clinical trials

Never miss an issue!

Login

Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began